Author Guidelines

Overview

The Journal of Advanced Ayurveda Research & Innovation (JARI) welcomes original, high-quality scholarly contributions that advance knowledge in Ayurveda, Panchakarma, Integrative Medicine, Traditional Medical Systems, Digital Health, Artificial Intelligence in Healthcare, Public Health, Medical Education and related interdisciplinary fields.

JARI seeks scientifically rigorous, ethically conducted and transparently reported scholarship. The journal encourages concise communication while prioritising scientific completeness, methodological transparency and reproducibility over rigid manuscript length.

 

Manuscript Length and Page Limits

JARI provides recommended manuscript lengths according to article type rather than rigid page limits. The recommended ranges are intended to promote focused scientific communication and should not prevent complete and transparent reporting.

 

JARI does not prescribe a fixed manuscript page limit.

Manuscripts exceeding a recommended word range will not be rejected solely on the basis of length where the additional content is scientifically justified. Authors should not omit essential methodological, clinical, statistical or intervention details solely to meet a recommended word count.

Main-text word count excludes the title page, abstract, references, tables, figure legends, acknowledgements and supplementary material.

 

Types of Manuscripts and Recommended Specifications

Original Research Article

Reports of original clinical, experimental, observational, laboratory, educational or interdisciplinary research.

Abstract: Maximum 250 words

Recommended main text: 3,000–8,000 words

References: As scientifically appropriate

Tables/Figures: As scientifically necessary

 

Systematic Review / Meta-analysis

Structured evidence syntheses conducted using appropriate systematic methods.

Abstract: Maximum 250 words

Recommended main text: 4,000–10,000 words

References: No fixed numerical limit

Tables/Figures: As scientifically necessary

 

Scoping Review

Evidence-mapping reviews conducted using an appropriate scoping-review methodology.

Abstract: Maximum 250 words

Recommended main text: 4,000–10,000 words

References: No fixed numerical limit

Tables/Figures: As scientifically necessary

 

Narrative / Critical Review

Comprehensive and critical scholarly reviews of current evidence, concepts or emerging developments.

Abstract: Maximum 250 words

Recommended main text: 4,000–10,000 words

References: As scientifically appropriate

Tables/Figures: As scientifically necessary

 

Case Report

Unique or educational clinical cases with significant scientific or clinical relevance.

Abstract: Maximum 200 words

Recommended main text: 1,500–3,500 words

References: Normally concise

Tables/Figures: Normally up to 5 display items

 

Case Series

Reports of multiple related clinical cases with a clear scientific or educational rationale.

Abstract: Maximum 250 words

Recommended main text: 2,000–4,500 words

References: As scientifically appropriate

Tables/Figures: As scientifically necessary

 

Short Communication

Brief reports of novel findings, preliminary studies or focused research observations.

Abstract: Maximum 200 words

Recommended main text: 1,000–2,500 words

References: Normally concise

Tables/Figures: Normally up to 4 display items

 

Innovation & Technical Note

Descriptions or evaluations of new technologies, devices, software, procedures, methodologies or healthcare innovations.

Abstract: Maximum 250 words

Recommended main text: 1,500–4,000 words

References: As scientifically appropriate

Tables/Figures: As scientifically necessary

 

Study Protocol / Methodology Article

Protocols, methodological developments or detailed descriptions of scientifically relevant study methods.

Abstract: Maximum 250 words

Recommended main text: 2,500–6,000 words

References: As scientifically appropriate

Tables/Figures: As scientifically necessary

 

Perspective / Viewpoint

Evidence-informed scholarly perspectives on important or emerging issues relevant to JARI’s scope.

Abstract: Maximum 200 words

Recommended main text: 1,500–3,000 words

References: Normally concise

Tables/Figures: Normally up to 4 display items

 

Editorial

Usually commissioned or invited scholarly commentary on topics relevant to the journal or a specific issue.

Abstract: Maximum 150 words, if required

Recommended main text: 1,000–2,000 words

References: Normally concise

Tables/Figures: Normally up to 2 display items

 

Letter to the Editor

Focused scholarly correspondence relating to published work or issues relevant to the journal.

Abstract: Not required

Main text: Up to 1,000 words

References: Normally up to 15

Tables/Figures: Normally up to 2 display items

 

Reference Policy

JARI does not impose a fixed maximum number of references for full-length research and review articles. References should be relevant, accurate, proportionate to the scope and methodology of the manuscript, and free of unnecessary duplication. Systematic reviews, scoping reviews, meta-analyses and other evidence-synthesis articles may include all references required for comprehensive and transparent reporting. JARI follows the Vancouver Reference Style.

 

Manuscript Language

All submissions must be written in clear academic English. Authors whose first language is not English are encouraged to obtain appropriate language editing before submission.

 

Manuscript Formatting Requirements

Accepted file formats:

Microsoft Word (.doc or .docx)

Rich Text Format (.rtf)

 

General formatting:

A4 page size

1-inch margins on all sides

Times New Roman

12-point font

1.5 line spacing

Page numbers included

 

Title Page — Separate File

 The title page should include:

Full article title

Running title

Article type

Author names

Institutional affiliations

ORCID iDs, where available

Corresponding author details

Abstract and main-text word counts

Number of tables and figures

Number of supplementary files

Funding information

Conflict of interest declaration

Ethical approval and clinical trial registration, where applicable

Reporting guideline used, where applicable

Data availability information

AI disclosure, where applicable

 

Blinded Manuscript File

The manuscript submitted for double-blind peer review must not contain identifying information. Do not include author names, affiliations, email addresses, identifying acknowledgements or self-identifying statements.

 

Abstract and Keywords

All manuscripts requiring an abstract must comply with the article-specific limit above.

 

Original Research Articles should ordinarily use a structured abstract containing:

Background

Objective(s)

Materials and Methods

Results

Conclusion

Other article types should follow the abstract structure required by the applicable reporting guideline or JARI article-specific instructions.

Citations, tables and figures should not ordinarily appear in the abstract.

Provide 3–8 keywords immediately below the abstract. Authors are encouraged to use standardised indexing terms, including MeSH terminology where appropriate.

 

Reporting Guidelines

Authors must follow the reporting guideline appropriate to the study design where an applicable guideline exists.

Examples include:

Randomised controlled trials — CONSORT

Observational studies — STROBE

Systematic reviews and meta-analyses — PRISMA

Scoping reviews — PRISMA-ScR

Case reports — CARE

Study protocols — SPIRIT, where applicable

Diagnostic accuracy studies — STARD

Animal studies — ARRIVE

Qualitative research — COREQ or SRQR, as appropriate

Completed reporting checklists and flow diagrams should be uploaded as supplementary files where applicable.

 

Reporting of Ayurveda and Traditional Medicine Interventions

Studies involving Ayurveda or other traditional medical interventions must provide sufficient methodological detail for scientific evaluation and, where appropriate, clinical reproducibility.

Authors should report, as applicable:

Precise name and nature of the intervention

Formulation composition and ingredients

Botanical identity and plant part, where relevant

Manufacturer or source and relevant product information

Dose or quantity

Route of administration

Frequency and duration

Timing in relation to meals or procedures

Relevant Purvakarma, Pradhana Karma and Paschat Karma

Procedural parameters for Panchakarma and other therapeutic procedures

Criteria used for individualisation, treatment modification or dose adjustment

Concomitant therapies and co-interventions

Treatment adherence

Adverse events and safety observations

Statements such as “treatment was administered according to classical Ayurveda principles” without sufficient procedural description may be considered inadequate where reproducible details can reasonably be provided.

 

Tables, Figures and Clinical Images

JARI does not ordinarily impose a rigid universal numerical limit on tables and figures for full-length research and review articles. Authors should include only those display items necessary for clear and complete scientific presentation. Approximately 6–8 combined tables and figures will ordinarily be sufficient for most full-length manuscripts; additional items may be accepted where scientifically justified or transferred to supplementary material.

Tables must be editable, numbered consecutively, cited in the text, and provided with concise descriptive titles. Information should not be unnecessarily duplicated between text, tables and figures.

Figures include graphs, diagrams, flowcharts, clinical photographs, radiological images, microscopy images and other illustrations. Figures must be numbered consecutively, cited in the manuscript and accompanied by concise legends.

Photographic and continuous-tone images should preferably be submitted at a minimum resolution of 300 dpi. Higher resolution may be requested for line drawings or figures containing fine detail.

Multi-panel figures should form a scientifically coherent composite and should not be created solely to circumvent display-item guidance.

Image manipulation that alters, obscures, introduces or misrepresents scientifically relevant information is prohibited.

 

Clinical Photographs and Patient Confidentiality

Authors must protect patient confidentiality. Written informed consent for publication must be obtained where an individual may be identifiable from a photograph, image or accompanying information. Authors must retain the original consent documentation and provide confirmation or documentation to JARI if requested.

 

Supplementary Material

Supporting material that is useful but not essential to the main article may be submitted as supplementary material, including:

Reporting-guideline checklists

Additional tables and figures

Detailed methodological information

Questionnaires or assessment instruments

Datasets or data dictionaries, where appropriate

Additional statistical analyses

Multimedia or other supporting files

 

Statistical Reporting

Statistical methods should be described with sufficient detail to permit scientific evaluation. Where appropriate, authors should report effect estimates with suitable measures of uncertainty, such as 95% confidence intervals, rather than relying solely on p-values. Statistical tests, relevant assumptions, and statistical software/version should be reported where applicable.

 

Data Availability

Original research and other applicable manuscripts should include a Data Availability Statement describing whether and how data supporting the findings may be accessed. Where ethical, legal, privacy, participant-consent or proprietary restrictions prevent public sharing, these limitations should be clearly stated.

 

Ethical Requirements

Research involving human participants must include appropriate Institutional Ethics Committee or equivalent approval, informed consent and protection of participant confidentiality.

Research involving animals must comply with applicable institutional and national ethical requirements.

 

Clinical Trial Registration

Applicable interventional clinical trials must be prospectively registered in a publicly accessible primary registry recognised by the WHO International Clinical Trials Registry Platform (WHO ICTRP), such as the Clinical Trials Registry–India (CTRI) or another appropriate recognised registry. Registration should occur before enrolment of the first participant. The registration number must be included in the manuscript.

 

Artificial Intelligence (AI) Policy

AI systems cannot be listed as authors. Authors remain fully responsible for the accuracy, originality, integrity, citations and scientific content of submitted work.

Use of generative AI or AI-assisted technologies that materially contributes to manuscript preparation, analysis, interpretation, generation of text or other substantive content must be transparently disclosed, including the tool used and the nature of its use.

Routine spelling, grammar, reference-management or formatting assistance that does not generate substantive scientific content does not ordinarily require disclosure.

AI tools must not be used to fabricate, falsify or misrepresent data, references, images, patient information, results or scientific findings.

 

Plagiarism and Research Integrity

All manuscripts may be screened using plagiarism-detection or other research-integrity tools. Similarity reports are interpreted by the Editorial Office and do not by themselves determine editorial decisions.

Fabrication, falsification, inappropriate image manipulation, duplicate publication and other forms of research misconduct are prohibited.

 

Conflict of Interest

Authors must disclose any financial, professional, institutional or personal relationships that could influence the work.

If none exist, state:

“The authors declare no conflict of interest.”

 

Funding Statement

All sources of financial support must be disclosed.

If no external funding was received, state:

“No external funding was received for this study.”

 

Copyright

Authors must complete the applicable JARI Submission Declaration & Publishing Licence requirements.

 

Peer Review

All eligible manuscripts undergo Double-Blind Peer Review. The identities of authors and reviewers remain confidential throughout the review process.

 

Publication Charges

Publication charges are described separately on the JARI Article Processing Charges (APC) page. JARI does not charge a manuscript submission fee.

 

Submission

Authors should submit manuscripts through the online submission system and ensure that all required documents are uploaded before final submission. Incomplete submissions may be returned for technical correction before peer review.

 

Editorial Screening

All submitted manuscripts undergo an initial editorial assessment for:

Suitability for the journal

Compliance with journal policies

Ethical requirements

Completeness of submission

Applicable reporting standards

Scientific and methodological presentation

Manuscripts not meeting these requirements may be returned to the authors for correction before peer review.

 

Articles per Issue

JARI does not prescribe a fixed numerical quota for articles published in an individual issue. The composition and number of articles in each issue are determined by the availability of manuscripts that have successfully completed editorial assessment, peer review, required revisions and final editorial approval. Publication decisions are based on scholarly merit and applicable editorial standards rather than the need to meet a predetermined article quota.

 

Contact

Questions regarding manuscript preparation or submission may be directed to the Editorial Office through the Contact page.